Loading the company…
Loading the company…
Families: Colorectal resection, Prostatectomy & nephrectomy.
All companies · Product and company coverage
In 2025, Asensus Surgical reported engagement with 15 surgeons and other clinicians in the states MedaRep covers, worth $13K in consulting, speaking, meals and travel for its device products, the most in Colorado ($11K to 7). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Colorado ($11K, 7 engaged), Vermont ($1,800, 1 engaged), Louisiana ($293, 2 engaged), Florida ($133, 2 engaged), New York ($67, 1 engaged).
In the last ten years FDA made 6 decisions for Asensus Surgical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2021 (2). The latest was on 2026-05-12.
| Family | Decisions on record |
|---|---|
| Colorectal resection | 6 |
| Prostatectomy & nephrectomy | 6 |
| Senhance Surgical System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Asensus Surgical.